The role of the microenvironment in human immunodeficiency virus-associated classical Hodgkin lymphoma

被引:11
|
作者
Koulis, Athanasios [1 ]
Trivedi, Pritesh [1 ]
Ibrahim, Hazem [1 ,3 ]
Bower, Mark [2 ]
Naresh, Kikkeri N. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, London, England
[2] Chelsea Westminster Hosp, Dept Med Oncol, London, England
[3] Mansoura Univ, Dept Histopathol, Fac Med, Mansoura, Egypt
关键词
classical Hodgkin lymphoma; human immunodeficiency virus; human immunodeficiency virus-associated classical Hodgkin lymphoma; immune system cells; inflammation; tumour microenvironment; ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED INDIVIDUALS; EPSTEIN-BARR-VIRUS; T-CELLS; DISEASE; PATHOGENESIS; LYMPHOCYTES; PHENOTYPE; NUMBER;
D O I
10.1111/his.12458
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
AimsTo characterize the microenvironment of classical Hodgkin lymphoma (cHL) in people living with human immunodeficiency virus (PLWH). The objective was to identify and then quantify the immune cells present in the microenvironment. Methods and resultsTen samples of cHL from PLWH were compared with 10 samples of cHL from the general population using tissue microarray technology and immunohistochemistry. Sections were immunostained with antibodies for CD30, CD3, CD4, CD8, CD20, CD68R, CD56, CD57, CD123, FoxP3 and granzyme B. A statistically significant reduction of CD4(+) T cells, CD56(+) cells, CD57(+) cells, CD123(+) cells and B cells and an increase in numbers in FoxP3(+)CD8(+) cells was observed in cHL diagnosed in PLWH. No significant differences were seen in the number of CD8(+) T cells, CD4(+)FoxP3(+) T cells and macrophages. ConclusionThere are considerable differences in the microenvironment of cHL occurring with and without HIV.
引用
收藏
页码:749 / 756
页数:8
相关论文
共 50 条
  • [1] Clinical characteristics of human immunodeficiency virus-associated Hodgkin lymphoma patients in Japan
    Yotsumoto, Mihoko
    Hagiwara, Shotaro
    Ajisawa, Atsushi
    Tanuma, Junko
    Uehira, Tomoko
    Nagai, Hirokazu
    Fujikawa, Yuko
    Maeda, Shunichi
    Kitano, Kiyoshi
    Arima, Nobuyoshi
    Uno, Kenji
    Iwai, Toshiki
    Hongo, Igen
    Ota, Yasunori
    Fukutake, Katsuyuki
    Okada, Seiji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (02) : 247 - 253
  • [2] Epstein Barr Virus-Associated Hodgkin Lymphoma
    Carbone, Antonino
    Gloghini, Annunziata
    CANCERS, 2018, 10 (06)
  • [3] Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma
    Ezzat, Hatoon M.
    Cheung, Matthew C.
    Hicks, Lisa K.
    Boro, Jordana
    Montaner, Julio S. G.
    Lima, Viviane Dias
    Harris, Marianne
    Leitch, Heather A.
    LEUKEMIA & LYMPHOMA, 2012, 53 (12) : 2390 - 2396
  • [4] Human immunodeficiency virus-associated anaplastic large cell lymphoma
    Perez, Kimberly
    Castillo, Jorge
    Dezube, Bruce J.
    Pantanowitz, Liron
    LEUKEMIA & LYMPHOMA, 2010, 51 (03) : 430 - 438
  • [5] THE ROLE OF EPSTEIN-BARR-VIRUS SUBTYPES IN HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED LYMPHOMA
    BOYLE, MJ
    SCULLEY, TB
    PENNY, R
    SEWELL, WA
    TSCHUCHNIGG, M
    BERGER, MF
    COOPER, DA
    LEUKEMIA & LYMPHOMA, 1993, 10 (1-2) : 17 - 23
  • [6] Microenvironment in classical Hodgkin lymphoma
    Mottok, Anja
    PATHOLOGE, 2020, 41 (03): : 254 - 260
  • [7] How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus
    Uldrick, Thomas S.
    Little, Richard F.
    BLOOD, 2015, 125 (08) : 1226 - 1235
  • [8] Human Immunodeficiency Virus-Associated Malignancies: A Therapeutic Update
    Malfitano, Antonello
    Barbaro, Giuseppe
    Perretti, Alessandro
    Barbarini, Giorgio
    CURRENT HIV RESEARCH, 2012, 10 (02) : 123 - 132
  • [9] Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma
    Martynchyk, Arina
    Chowdhury, Rakin
    Hawkes, Eliza A.
    Keane, Colm
    CANCERS, 2023, 15 (21)
  • [10] Human immunodeficiency virus-associated thrombotic microangiopathies
    Gilardin, L.
    Malak, S.
    Schoindre, Y.
    Galicier, L.
    Veyradier, A.
    Coppo, P.
    REVUE DE MEDECINE INTERNE, 2012, 33 (05): : 259 - 264